Anika Therapeutics, Inc. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
Anika Therapeutics, Inc. (ANIK) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $28.88 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-02-27
- Anika Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $28.88M, a 2.08% increase year-over-year.
- Anika Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $27.18M, a 5.41% increase year-over-year.
- Anika Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $28.34M, a 6.64% increase year-over-year.
- Anika Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $23.38M, a 4.95% increase year-over-year.
- Anika Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $107.78M, a 4.71% increase from fiscal 2016.
- Anika Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $102.93M, a 17.37% increase from fiscal 2015.
- Anika Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $87.70M, a 16.19% increase from fiscal 2014.
- Anika Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $75.47M, a 5.16% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 1 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $28.88M 10-K · filed 2018-02-27 | $56.06M derived: sum of 2 quarters · filed 2018-02-27 | $84.40M derived: sum of 3 quarters · filed 2018-02-27 | $107.78M 10-K · filed 2018-02-27 | |||||
| 2017-09-30 | $27.18M 10-K · filed 2018-02-27 | $55.52M derived: sum of 2 quarters · filed 2018-02-27 | $78.90M 10-Q · filed 2017-10-27 | $107.19M derived: sum of 4 quarters · filed 2018-02-27 | |||||
| 2017-06-30 | $28.34M 10-K · filed 2018-02-27 | $51.72M 10-Q · filed 2017-07-28 | $80.02M derived: sum of 3 quarters · filed 2018-02-27 | $105.80M derived: sum of 4 quarters · filed 2018-02-27 | |||||
| 2017-03-31 | $23.38M 10-K · filed 2018-02-27 | $51.68M derived: sum of 2 quarters · filed 2018-02-27 | $77.46M derived: sum of 3 quarters · filed 2018-02-27 | $104.03M derived: sum of 4 quarters · filed 2018-02-27 | |||||
| 2016-12-31 | $28.30M 10-K · filed 2018-02-27 | $54.08M derived: sum of 2 quarters · filed 2018-02-27 | $80.65M derived: sum of 3 quarters · filed 2018-02-27 | $102.93M 10-K · filed 2018-02-27 | |||||
| 2016-09-30 | $25.78M 10-K · filed 2018-02-27 | $52.36M derived: sum of 2 quarters · filed 2018-02-27 | $74.64M 10-Q · filed 2017-10-27 | $100.24M derived: sum of 4 quarters · filed 2018-02-27 | |||||
| 2016-06-30 | $26.57M 10-K · filed 2018-02-27 | $48.85M 10-Q · filed 2017-07-28 | $74.46M derived: sum of 3 quarters · filed 2018-02-27 | $98.14M derived: sum of 4 quarters · filed 2018-02-27 | |||||
| 2016-03-31 | $22.28M 10-K · filed 2018-02-27 | $47.88M derived: sum of 2 quarters · filed 2018-02-27 | $71.56M derived: sum of 3 quarters · filed 2018-02-27 | $94.46M derived: sum of 4 quarters · filed 2018-02-27 | |||||
| 2015-12-31 | $25.61M 10-K · filed 2017-02-24 | $49.28M derived: sum of 2 quarters · filed 2017-02-24 | $72.18M derived: sum of 3 quarters · filed 2017-02-24 | $87.70M 10-K · filed 2018-02-27 | |||||
| 2015-09-30 | $23.68M 10-K · filed 2017-02-24 | $23.68M 10-Q · filed 2015-11-03 | $46.57M derived: sum of 2 quarters · filed 2017-02-24 | $62.09M 10-Q · filed 2016-11-01 | $62.09M 10-Q · filed 2015-11-03 | $79.97M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-06-30 | $22.90M 10-K · filed 2017-02-24 | $22.90M 10-Q · filed 2015-08-04 | $38.41M 10-Q · filed 2016-08-01 | $38.41M 10-Q · filed 2015-08-04 | $56.29M derived: sum of 3 quarters · filed 2017-02-24 | $78.27M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-03-31 | $15.52M 10-K · filed 2017-02-24 | $15.51M 10-Q · filed 2015-05-04 | $33.40M derived: sum of 2 quarters · filed 2017-02-24 | $55.37M derived: sum of 3 quarters · filed 2017-02-24 | $76.64M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | $17.88M 10-K · filed 2016-03-10 | $17.88M 10-K · filed 2015-03-13 | $39.85M derived: sum of 2 quarters · filed 2016-03-10 | $61.12M derived: sum of 3 quarters · filed 2016-03-10 | $75.47M 10-K · filed 2017-02-24 | $75.47M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $21.98M 10-K · filed 2016-03-10 | $21.98M 10-Q · filed 2014-11-06 | $43.24M derived: sum of 2 quarters · filed 2016-03-10 | $57.59M 10-Q · filed 2015-11-03 | $77.78M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $21.27M 10-K · filed 2016-03-10 | $21.27M 10-Q · filed 2014-08-04 | $35.62M 10-Q · filed 2015-08-04 | $55.81M derived: sum of 3 quarters · filed 2016-03-10 | $72.83M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $14.35M 10-Q · filed 2014-05-05 | $14.35M 10-K · filed 2016-03-10 | $14.35M 10-Q · filed 2014-05-05 | $34.54M derived: sum of 2 quarters · filed 2016-03-10 | $51.56M derived: sum of 3 quarters · filed 2016-03-10 | $71.63M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2013-12-31 | $20.19M 10-K · filed 2015-03-13 | $37.21M derived: sum of 2 quarters · filed 2015-03-13 | $57.28M derived: sum of 3 quarters · filed 2015-03-13 | $71.77M 10-K · filed 2016-03-10 | $71.77M 10-K · filed 2014-03-13 | ||||
| 2013-09-30 | $17.02M 10-K · filed 2015-03-13 | $37.09M derived: sum of 2 quarters · filed 2015-03-13 | $51.59M 10-Q · filed 2014-11-06 | $73.04M derived: sum of 4 quarters · filed 2015-03-13 | |||||
| 2013-06-30 | $20.07M 10-K · filed 2015-03-13 | $34.56M 10-Q · filed 2014-08-04 | $56.02M derived: sum of 3 quarters · filed 2015-03-13 | $70.08M derived: sum of 4 quarters · filed 2015-03-13 | |||||
| 2013-03-31 | $14.49M 10-Q · filed 2014-05-05 | $14.49M 10-K · filed 2015-03-13 | $35.95M derived: sum of 2 quarters · filed 2015-03-13 | $50.01M derived: sum of 3 quarters · filed 2015-03-13 | $68.89M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $21.46M 10-K · filed 2014-03-13 | $35.51M derived: sum of 2 quarters · filed 2014-03-13 | $54.40M derived: sum of 3 quarters · filed 2014-03-13 | $68.01M 10-K · filed 2015-03-13 | |||||
| 2012-09-30 | $14.06M 10-K · filed 2014-03-13 | $32.94M derived: sum of 2 quarters · filed 2014-03-13 | $46.55M 10-Q · filed 2013-11-05 | $64.28M derived: sum of 4 quarters · filed 2014-03-13 | |||||
| 2012-06-30 | $18.88M 10-K · filed 2014-03-13 | $32.50M 10-Q · filed 2013-08-06 | $50.22M derived: sum of 3 quarters · filed 2014-03-13 | $67.98M derived: sum of 4 quarters · filed 2014-03-13 | |||||
| 2012-03-31 | $13.61M 10-K · filed 2014-03-13 | $31.34M derived: sum of 2 quarters · filed 2014-03-13 | $49.09M derived: sum of 3 quarters · filed 2014-03-13 | $64.51M derived: sum of 4 quarters · filed 2014-03-13 | |||||
| 2011-12-31 | $17.73M 10-K · filed 2013-03-14 | $35.48M derived: sum of 2 quarters · filed 2013-03-14 | $50.90M derived: sum of 3 quarters · filed 2013-03-14 | $61.96M 10-K · filed 2014-03-13 | |||||
| 2011-09-30 | $17.76M 10-K · filed 2013-03-14 | $33.17M derived: sum of 2 quarters · filed 2013-03-14 | $44.23M 10-Q · filed 2012-11-08 | $58.42M derived: sum of 4 quarters · filed 2013-03-14 | |||||
| 2011-06-30 | $15.41M 10-K · filed 2013-03-14 | $26.47M 10-Q · filed 2012-08-07 | $40.67M derived: sum of 3 quarters · filed 2013-03-14 | $53.85M derived: sum of 4 quarters · filed 2013-03-14 | |||||
| 2011-03-31 | $11.06M 10-K · filed 2013-03-14 | $25.25M derived: sum of 2 quarters · filed 2013-03-14 | $38.43M derived: sum of 3 quarters · filed 2013-03-14 | $52.15M derived: sum of 4 quarters · filed 2013-03-14 | |||||
| 2010-12-31 | $14.19M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $27.37M derived: sum of 2 quarters · filed 2013-03-14 | $41.09M derived: sum of 3 quarters · filed 2013-03-14 | $52.74M 10-K · filed 2013-03-14 | |||||
| 2010-09-30 | $13.18M 10-Q · filed 2011-11-04 | $26.90M derived: sum of 2 quarters · filed 2011-11-04 | $38.54M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | $13.72M 10-Q/A · filed 2011-08-10 | $25.36M 10-Q/A · filed 2011-08-10 | |||||||
| 2009-12-31 | $37.32M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |